Hallador Energy Company Reports Second Quarter 2020 Financial and Operating Results
TERRE HAUTE, Ind., Aug. 03, 2020 (GLOBE NEWSWIRE) — Hallador Energy Company (NASDAQ – HNRG) today reported income of $0.25 million, $0.01 per […]
Coherus BioSciences Appoints Kimberly Tzoumakas, J.D. to Board of Directors
REDWOOD CITY, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced the appointment of […]
Kimball Electronics, Inc. Announces Live Webcast of Fourth Quarter and Fiscal Year 2020 Financial Results Conference Call
JASPER, Ind., Aug. 03, 2020 (GLOBE NEWSWIRE) — Kimball Electronics, Inc. (NASDAQ: KE) will announce its fourth quarter fiscal year […]
Prospect Capital Corporation Launches $1 Billion 5.5% Perpetual Preferred Stock Offering
NEW YORK, Aug. 03, 2020 (GLOBE NEWSWIRE) — Prospect Capital Corporation (NASDAQ:PSEC) (“Prospect”) announced today a continuous preferred stock offering […]
Green Plains Partners Reports Second Quarter 2020 Financial Results
Results for the Second Quarter of 2020Net income of $10.2 million, or $0.43 per common unitAdjusted EBITDA of $13.2 million […]
AppFolio, Inc. Announces Second Quarter 2020 Financial Results
SANTA BARBARA, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE) — AppFolio, Inc. (NASDAQ: APPF) (“AppFolio” or the “Company”), a leading provider […]
vTv Therapeutics Announces 2020 Second Quarter Financial Results and Update
HIGH POINT, N.C., Aug. 03, 2020 (GLOBE NEWSWIRE) — vTv Therapeutics Inc. (Nasdaq:VTVT) today reported financial results for the second […]
Voyager Therapeutics to Report Second Quarter 2020 Financial Results and Participate in Upcoming Investor Conferences
CAMBRIDGE, Mass., Aug. 03, 2020 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on […]
Zoom Video Communications to Release Results for the Second Quarter of Fiscal Year 2021
SAN JOSE, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE) — Zoom Video Communications, Inc. (NASDAQ: ZM) will release results for its […]
AlloVir Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
CAMBRIDGE, Mass., Aug. 03, 2020 (GLOBE NEWSWIRE) — AlloVir, Inc. (Nasdaq: ALVR), a late clinical-stage cell therapy company, today announced […]
